UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000035828
Receipt No. R000040338
Scientific Title Serum soluble (pro)renin receptor concentration at initiation of hemodialysis therapy
Date of disclosure of the study information 2019/03/15
Last modified on 2019/01/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Serum soluble (pro)renin receptor concentration at initiation of hemodialysis therapy
Acronym Serum soluble (pro)renin receptor concentration at initiation of hemodialysis therapy
Scientific Title Serum soluble (pro)renin receptor concentration at initiation of hemodialysis therapy
Scientific Title:Acronym Serum soluble (pro)renin receptor concentration at initiation of hemodialysis therapy
Region
Japan

Condition
Condition chronic renal failure (at the initiation of hemodialysis)
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To measure serum s(P)RR values at the initiation of hemodialysis and to investigate the relationships between serum s(P)RR levels and background factors
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1) serum s(P)RR values at the initiation of hemodialysis
2) the relationships between serum s(P)RR levels and background factors
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria patients with chronic renal failure at the initiation of hemodialysis
Key exclusion criteria other than above
Target sample size 200

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name amari yoshifumi
Organization Moriguchi Keijinkai Hospital
Division name Department of Nephrology
Zip code
Address 2-47-12 Yagumohigashi-cho, Moriguchi-city, Osaka, Japan
TEL 0669069191
Email yoshifumi.0315@gmail.com

Public contact
Name of contact person
1st name
Middle name
Last name amari yoshifumi
Organization Moriguchi Keijinkai Hospital
Division name Department of Nephrology
Zip code
Address 2-47-12 Yagumohigashi-cho, Moriguchi-city, Osaka, Japan
TEL 0669069191
Homepage URL
Email yoshifumi.0315@gmail.com

Sponsor
Institute Moriguchi Keijinkai Hospital
Institute
Department

Funding Source
Organization tokyo women's medical university, tokyo, japan
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 03 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 01 Month 01 Day
Date of IRB
Anticipated trial start date
2020 Year 12 Month 31 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Risk of developing cardiovascular events, prognosis

Management information
Registered date
2019 Year 02 Month 10 Day
Last modified on
2019 Year 01 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040338

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.